.png)
The 9th
Annual Cure Cup
April 29, 2024 - Lake Nona Golf & Country Club
The Cause is - The Cure
Funds raised from the Cure Cup will support cancer research being conducted at UCF College of Medicine and at its UCF Lake Nona Cancer Center.
At the UCF College of Medicine and its Lake Nona Cancer Center researchers are on the vanguard of cancer biology, investigating:
​
-
How patients’ genes play a role in their cancer risk.
-
What causes cancer and cancer metastasis.
-
How cancer cells communicate with the neighboring normal cells.
-
The epigenetic changes that play a role in developing drug resistance.
-
Discovering new ways to harness the immune system to fight cancer.
-
Identifying new targets for companion diagnostics with treatments that reduce side effects
UCF College of Medicine and its Lake Nona Cancer Center offers a collaborative approach harnessing expertise in cutting edge sciences to bring the world closer to finding a cure for cancers that cause human mortality. Research is being conducted on many forms of cancer — like the metastatic forms of breast and prostate cancer — and the rapidly progressing types of pancreatic, lung, ovarian and head and neck cancers.
​
​
UCF Researcher Finds New Signal To Predict Breast Cancer Growth
​
A tiny piece of a protein could be key to keep breast cancer from growing.
A discovery at the University of Central Florida College of Medicine may in the future help detect cancer cells in patients before these cells have a chance to metastasize or spread through the body.
​
Shown here is Dr. Annette Khaled a cancer researcher who has spent the last ten years studying ways to inhibit breast cancer metastases, published her lab’s results in last month’s Scientific Reports. Dr. Khaled leads the medical school’s cancer research division and is looking at how and why cells escape the primary cancer tumor and then spread to organs like the lungs, brain, and bones, where they cause 90 percent of cancer deaths. Supported with funding from the National Institutes of Health (NIH) and the Breast Cancer Research Foundation, she previously was able to show that a molecular complex called a chaperonin or CCT for short, which helps proteins to fold into functional units, is especially active in cancer cells.